Tag Archives: PGNX

Top 5 Low Price Stocks To Watch Right Now

EMM & QNX will be the growth drivers going forward. But the risks in BlackBerry stock continue to remain elevated.

BlackBerry(NSDQ:BBRY)stock is a very volatile stock. When the company announced its latest set of earnings on the 20th of December, the share price rose to around $8 a share, but since then has plummeted back down to the $7 level. Blackberry is unique in that it is a low priced stock but is just as liquid as many of its peers. This combined with the volatility of the tech sector attracts all types of investors and traders as volatility is a guarantee (which we have obviously seen over the past week or so).

BlackBerry’s latest fiscal third quarter was definitely a mixed bag. On one hand, you had aggressive margin expansion and a surprising profitable quarter on a non-GAAP basis, but on the other hand, top line came in $20 million short of what was expected. A return to revenue growth is expected next year with enterprise software & QNX probably leading the way. Blackberryand its investors know that if this company can comprehensively combine these areas as well as its security wing to work cohesively in the emerging Internet Of Things market (IoT), then this company will have a strategic competitive advantage. Blackberry’s pivot from hardware to software may have been well timed but I would still recommend caution. Here are three reasons to back up my case.

Top 5 Low Price Stocks To Watch Right Now: Progenics Pharmaceuticals Inc.(PGNX)

Advisors’ Opinion:

  • [By Cory Renauer]

    Here’s what you need to know about the catalysts that could send these stocks soaring, or plummeting, in the third quarter.

    Company Market Cap Incoming Catalyst
    Spark Therapeutics Inc. (NASDAQ:ONCE) $3.09 billion Clinical trial results
    Zogenix, Inc. (NASDAQ:ZGNX) $1.56 billion Clinical trial results
    Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) $593 million PDUFA date

    Data source: Yahoo! Finance.

  • [By Chris Lange]

    Progenics Pharmaceuticals Inc. (NASDAQ: PGNX) has a PDUFA date set for July 30 for its malignant pheochromocytoma and paraganglioma treatment, Azedra.

  • [By Keith Speights]

    Neurocrine Biosciences (NASDAQ:NBIX), along with partner AbbVie (NYSE:ABBV), Progenics Pharmaceuticals (NASDAQ:PGNX), and Insys Pharmaceuticals (NASDAQ:INSY) await major approval decisions by the U.S. Food and Drug Administration (FDA). Here’s what you need to know about the potential catalysts for these biotech stocks.

Top 5 Low Price Stocks To Watch Right Now: T. Rowe Price Group, Inc.(TROW)

Advisors’ Opinion:

  • [By Shane Hupp]

    Press coverage about T. Rowe Price (NASDAQ:TROW) has trended somewhat positive on Wednesday, according to Accern. Accern rates the sentiment of news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. T. Rowe Price earned a news impact score of 0.20 on Accern’s scale. Accern also assigned media stories about the asset manager an impact score of 47.382716620203 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Thermo Fisher Scientific Inc. (NYSE: TMO) is projected to report quarterly earnings at $2.4 per share on revenue of $5.63 billion.
    Ford Motor Company (NYSE: F) is expected to report quarterly earnings at $0.41 per share on revenue of $37.16 billion.
    Twitter, Inc. (NYSE: TWTR) is projected to report quarterly earnings at $0.11 per share on revenue of $605.26 million.
    Comcast Corporation (NASDAQ: CMCSA) is expected to report quarterly earnings at $0.59 per share on revenue of $22.75 billion.
    General Dynamics Corporation (NYSE: GD) is estimated to report quarterly earnings at $2.52 per share on revenue of $7.6 billion.
    The Boeing Company (NYSE: BA) is expected to report quarterly earnings at $2.58 per share on revenue of $22.24 billion.
    Anthem, Inc. (NYSE: ANTM) is estimated to report quarterly earnings at $4.91 per share on revenue of $22.52 billion.
    Viacom, Inc. (NASDAQ: VIAB) is projected to report quarterly earnings at $0.79 per share on revenue of $3.04 billion.
    Northrop Grumman Corporation (NYSE: NOC) is estimated to report quarterly earnings at $3.61 per share on revenue of $6.61 billion.
    Rockwell Automation Inc. (NYSE: ROK) is expected to report quarterly earnings at $1.81 per share on revenue of $1.66 billion.
    Wipro Limited (NYSE: WIT) is projected to report quarterly earnings at $0.07 per share on revenue of $2.15 billion.
    The Goodyear Tire & Rubber Company (NASDAQ: GT) is expected to report quarterly earnings at $0.46 per share on revenue of $3.82 billion.
    Owens Corning (NYSE: OC) is projected to report quarterly earnings at $0.97 per share on revenue of $1.62 billion.
    T. Rowe Price Group, Inc. (NASDAQ: TROW) is estimated to report quarterly earnings at $1.71 per share on revenue of $1.29 billion.
    Dr Pepper Snapple Group, Inc. (NYSE: DPS) is expected to report quarterly earnings at $1.04 per share on revenue of $1.57 billion.
    Sirius XM Holdings Inc. (NASDAQ: SI
  • [By Max Byerly]

    T. Rowe Price Group Inc (NASDAQ:TROW) Director Robert F. Maclellan sold 5,000 shares of T. Rowe Price Group stock in a transaction on Wednesday, May 30th. The shares were sold at an average price of $122.58, for a total value of $612,900.00. Following the completion of the transaction, the director now owns 13,769 shares in the company, valued at $1,687,804.02. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Top 5 Low Price Stocks To Watch Right Now: Snap-On Incorporated(SNA)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Mountain Pacific Investment Advisers Inc. ID reduced its stake in Snap-on (NYSE:SNA) by 0.3% during the 1st quarter, HoldingsChannel.com reports. The firm owned 154,025 shares of the company’s stock after selling 440 shares during the quarter. Snap-on makes up approximately 2.3% of Mountain Pacific Investment Advisers Inc. ID’s holdings, making the stock its 14th biggest holding. Mountain Pacific Investment Advisers Inc. ID’s holdings in Snap-on were worth $22,725,000 at the end of the most recent reporting period.

  • [By Dan Caplinger]

    Thursday ended in the red for most major benchmarks on Wall Street, with the Dow trading down by triple digits at times before climbing back toward the close. After having bounced back sharply in recent days, stocks seemed to lose upward momentum, and interest rate fears returned to the market. The yield on the 10-year Treasury bond once again moved above the 2.9% mark, and shorter-term Treasurys had yields reach levels they haven’t seen in years. Yet even though the overall market was ready to take a break, some companies still enjoyed good news that lifted their shares. Bank of New York Mellon (NYSE:BK), Snap-on (NYSE:SNA), and Rigel Pharmaceuticals (NASDAQ:RIGL) were among the best performers on the day. Here’s why they did so well.

  • [By Logan Wallace]

    American Century Companies Inc. reduced its position in Snap-on (NYSE:SNA) by 93.6% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 17,330 shares of the company’s stock after selling 253,734 shares during the quarter. American Century Companies Inc.’s holdings in Snap-on were worth $2,557,000 as of its most recent SEC filing.

Top 5 Low Price Stocks To Watch Right Now: ServiceMaster Global Holdings, Inc.(SERV)

Advisors’ Opinion:

  • [By Max Byerly]

    ServiceMaster (NYSE:SERV)’s share price reached a new 52-week high and low during trading on Tuesday . The company traded as low as $55.63 and last traded at $54.76, with a volume of 207508 shares traded. The stock had previously closed at $55.35.

  • [By Stephan Byrd]

    ServiceMaster (NYSE:SERV) insider Timothy M. Haynes sold 55,363 shares of the stock in a transaction that occurred on Thursday, May 3rd. The shares were sold at an average price of $53.18, for a total transaction of $2,944,204.34. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

  • [By Logan Wallace]

    Xact Kapitalforvaltning AB raised its stake in Servicemaster Global Holdings Inc (NYSE:SERV) by 33.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,711 shares of the business services provider’s stock after acquiring an additional 3,900 shares during the period. Xact Kapitalforvaltning AB’s holdings in Servicemaster Global were worth $799,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Servicemaster Global (SERV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Servicemaster Global Holdings Inc (NYSE:SERV) hit a new 52-week high and low during trading on Thursday . The company traded as low as $59.70 and last traded at $59.03, with a volume of 15886 shares trading hands. The stock had previously closed at $59.62.

Top 5 Low Price Stocks To Watch Right Now: Deutsche Bank AG(DB)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    Merger mania has been hitting Wall Street all month. Today, 21st Century Fox Inc. (Nasdaq: FOXA) has been urged by activist investor Chris Hohn to make a deal with Comcast Corp.(Nasdaq: CMCSA) if that company’s offer is better than the deal they could receive from The Walt Disney Co.(NYSE: DIS). Hohn’s firm disclosed in an SEC filing that it has a 7.4% stake in FOXA.
    Four Stocks to Watch Today: BBY, DB, KR, APRN
    Best Buy Corp.(NYSE: BBY) leads a busy day of earnings reports in New York. The Big Box retailer easily topped Wall Street expectations, with earnings per share of $0.82 on $9.11 billion in revenue. The average analyst expectation came in at $0.75 on $8.78 billion.
    The largest bank in Europe is facing problems again. This morning, Deutsche Bank AG(NYSE: DB) announced plans to slash 7,000 jobs as the firm attempts to restore profitability to its balance sheet. The announcement comes as the company’s chair faces a vote of no confidence at an annual general meeting taking place today.
    In other deal news, Kroger Inc. (NYSE: KR) has purchased Home Chef, the biggest privately owned meal kit delivery firm in the United States. The deal includes $200 million upfront and could be worth $700 million should Home Chef hit certain targets over its next five years. It is an interesting acquisition, given that rival Blue Apron Holdings Inc. (NYSE: APRN) has struggled since its IPO. Though APRN stock was up 3.8% this morning on news of the Home Chef deal, the stock is trading at just $3.07. It hit the market at $11.00 in June 2017. Look for additional earnings reports from Splunk Inc. (Nasdaq: SPLK), Deckers Outdoor Corp. (Nasdaq: DECK), Gap Inc. (NYSE: GPS), Ross Stores Inc.(Nasdaq: ROST), Autodesk Inc. (Nasdaq: ADSK), and Hormel Foods Corp. (NYSE: HRL).

    FollowMoney MorningonFacebook,Twitter, andLinkedIn.

  • [By ]

    As Deutsche Bank AG (DB) , Germany’s largest lender, retreats from its global ambitions in investment-banking and trading, Wall Street heavyweights JPMorgan Chase & Co. (JPM) , Citigroup Inc. (C) and Bank of America Corp. (BAC) are poised to pick up the business that’s left behind.

  • [By Ethan Ryder]

    Deutsche Bank (NYSE:DB)’s share price gapped down prior to trading on Wednesday . The stock had previously closed at $12.49, but opened at $12.90. Deutsche Bank shares last traded at $13.04, with a volume of 216758 shares changing hands.

  • [By Jordan Wathen, Dan Caplinger, and Sean Williams]

    Below, three Fool.com investors make the case for adding shares of Fifth Third Bancorp (NASDAQ:FITB), BofI Holding(NASDAQ:BOFI), and Deutsche Bank (NYSE:DB) to your portfolio.

  • [By ]

    One of the best examples of a value trap is Deutsche Bank (NYSE: DB). In a nutshell, Deutsche Bank is the leading global bank at destroying shareholder value. The chart below illustrates this fact.

  • [By Paul Ausick]

    Deutsche Bank AG (NYSE: DB) fell by about 2.9% Wednesday to post a new 52-week low of $12.90 after closing at $13.29 on Tuesday. The 52-week high is $20.23. Volume of about 6.3 million was about 40% higher than the daily average of about 4 million. The bank had no specific news.

Top Stocks To Own For 2018

Sears is soaring today, and there is, thankfully, an obvious reason (I hate when there isn’t one). In this case, it’s the news that Bruce Berkowitz’s Fairholme Capital Management bought 286,000 shares of the stock from March 23 to March 27, following CEO Eddie Lampert’s purchase of more than 500,000 last week.

Getty Images

That’s sent shares of Sears soaring 11% yesterday, and another 17% to $11.02 at 3:30 p.m. today, helped, no doubt, by investors covering their short positions in the stock.

We get why investors would be enthusiastic about these purchases. When insiders buy shares its a sign that they’re putting their money where there mouths are, and willing to bet on the prospects of the company. That was the case when JPMorgan Chase (JPM) CEO Jamie Dimon bought shares of his bank near the market low in Feb. 2016.

Top Stocks To Own For 2018: Progenics Pharmaceuticals Inc.(PGNX)

Advisors’ Opinion:

  • [By Ben Levisohn]

    After meeting with the senior management team of Progenics (PGNX) , Valeant’s partner for oral Relistor, we continue to think that this drug would be a good addition to Valeant’s GI (gastrointestinal) franchise. The PDUFA date for oral Relistor is 7/19/16. AlthoughValeant is leading interactions with the FDA, Progenics is highly confident regarding an approval in July based on its discussions with Valeant. Progenics believes that oral Relistor could be a $1B+ opportunity for Valeant, even with the recent decrease in opioid usage. For context, we estimate ’16 sales of $9.9B for Valeant. An approval for oral Relistor would also help remind the Street that Valeant’s brand drug pipeline is underappreciated, in our view. We think pipeline advancements for brand drugs could drive multiple expansion forValeant shares (on P/E).

  • [By Lisa Levin]

    Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) shares shot up 29 percent to $6.37 after announcing the FDA approval of RELISTOR tablets for the treatment of opioid-induced constipation in adults with chronic non-cancer pain.

Top Stocks To Own For 2018: Capricor Therapeutics, Inc.(CAPR)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Marathon Patent Group Inc (NASDAQ: MARA) shares surged 30.2 percent to $5.01 after dropping 40.86 percent on Tuesday. Marathon Patent Group filed for sale of 1.85 million shares of common stock by selling stockholders.
    Capricor Therapeutics Inc (NASDAQ: CAPR) shares jumped 17.2 percent to $2.25 after the company reported the FDA clearance of Investigational New Drug application for CAP-1002.
    Rite Aid Corporation (NYSE: RAD) gained 13.2 percent to $2.15 following 16.5 percent rally on Tuesday.
    Photronics, Inc. (NASDAQ: PLAB) shares climbed 11.8 percent to $10.45 after the company reported stronger-than-expected earnings for its fourth quarter.
    China Distance Education Hldgs Ltd (ADR) (NYSE: DL) shares surged 11.3 percent to $8.67. China Distance Education reported Q4 profit of $5.9 million on revenue of $41.7 million.
    Cytokinetics, Inc. (NASDAQ: CYTK) shares gained 11 percent to $8.05 after falling 7.05 percent on Tuesday.
    Ooma Inc (NYSE: OOMA) shares surged 8.5 percent to $10.85 as the company posted strong Q3 results.
    Nuance Communications Inc. (NASDAQ: NUAN) climbed 8 percent to $17.12 after the company reported stronger-than-expected results for its fourth quarter on Tuesday.
    American Superconductor Corporation (NASDAQ: AMSC) surged 7.8 percent to $3.59 after the company reported $8 million in D-VAR system orders.
    Thermon Group Holdings Inc (NYSE: THR) rose 6.3 percent to $24.17. William Blair upgraded Thermon Group from Market Perform to Outperform.
    Domino's Pizza, Inc. (NYSE: DPZ) surged 6.1 percent to $182.88. Nomura upgraded Domino's from Neutral to Buy.
    Xencor Inc (NASDAQ: XNCR) rose 5.9 percent to $21.17. Cantor Fitzgerald initiated coverage on Xencor with an Overweight rating.
    Idera Pharmaceuticals Inc (NASDAQ: IDRA) gained 5.1 percent to $2.28 after the company disclosed that it has been granted FDA Fast Track designation for IMO-2125.
    Regal Entertainment Group (NYSE: RGC) gained 5.1 percent to

Top Stocks To Own For 2018: Del Taco Restaurants, Inc.(TACO)

Advisors’ Opinion:

  • [By ]

    Del Taco Restaurants (TACO) : “We have so many others in that group, why go with this one?”

    Snap (SNAP) : “I think this one is going nowhere.”

  • [By WWW.THESTREET.COM]

    Cramer’s game plan starts on Monday, with earnings from Del Taco Restaurants (TACO)  . Despite strong same-store sales last quarter, Cramer said he’s expecting a struggle this quarter.

  • [By Lee Jackson]

    Del Taco Restaurants Inc. (NASDAQ: TACO) had a director at the company selling stock last week. The board member shed a total of 831,314 sharesat between $11.40 and $11.84 apiece. The total for the sale was $10 million. The shares ended the weekat $12.36, in a 52-week range of$8.43 to $15.32. The consensus price target is $17.07.

Top Stocks To Own For 2018: NeuroMetrix Inc.(NURO)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    NeuroMetrix (NURO) makes and markets wearable neuro-stimulation therapeutic devices. Cash per share is $1.37, with the stock selling more than 20% below that.

Top Stocks To Own For 2018: Sohu.com Inc.(SOHU)

Advisors’ Opinion:

  • [By Lisa Levin]

    Sohu.com (NASDAQ: SOHU) shares rose 2.77% to touch a new 52-week high of $71.54. Analysts at Goldman Sachs upgraded the stock from neutral to conviction buy.

  • [By Lisa Levin]

    Sohu.com Inc (NASDAQ: SOHU) shares were also up, gaining 14 percent to $57.89. Sohu.com reported a Q2 loss of $1.85 per share on revenue of $461.168 million.

  • [By Belinda Cao]

    Sohu.com Inc. (SOHU), which sold a stake in its search unit to Tencent Holdings Ltd. (700), advanced 11 percent for the week to $72.06. It retreated 5.9 percent Sept. 20. Tencent, Chinas biggest Internet company by market value, paid $448 million for a 36.5 percent stake in Sohus Sogou unit last week and merge its own search service with Sogou.

  • [By Wayne Duggan]

    Sogou is Baidu’s biggest rival when it comes to mobile search engine market share. The app is owned by Sohu.com Inc (NASDAQ: SOHU), and its position as second fiddle to Baidu makes it most similar to Microsoft Corporation (NASDAQ: MSFT)’s Bing.

  • [By Roberto Pedone]

    Sohu.com (SOHU) is a Chinese online media, search, gaming, community and mobile service group. This stock closed up 7.5% to $69.61 in Monday’s trading session.

    Monday’s Volume: 4.90 million

    Three-Month Average Volume: 1.01 million

    Volume % Change: 351%

    From a technical perspective, SOHU ripped sharply higher here with heavy upside volume. This move pushed shares of SOHU into breakout territory, since the stock took out some near-term overhead resistance at $67.80. Shares of SOHU are now quickly moving within range of triggering another breakout trade. That trade will hit if SOHU manages to take out Monday’s high of $69.71 to its 52-week high at $70.63 with high volume.

    Traders should now look for long-biased trades in SOHU as long as it’s trending above Monday’s low of $66.95 or above that first breakout level of $67.80 and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.01 million shares. If that breakout hits soon, then SOHU will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $75 to $80.

  • [By Monica Gerson]

    Sohu.com Inc (NASDAQ: SOHU) is projected to report a quarterly loss at $0.57 per share on revenue of $406.50 million.

    Bank of Hawaii Corporation (NYSE: BOH) is expected to report its quarterly earnings at $0.99 per share on revenue of $149.88 million.

stock exchange hours

FRED DUFOUR/AFP/Getty Images

Why do we make things so complicated? Take retirement accounts for example. It seems like a simple concept. Enable people to save money tax-deferred during their working years, and then tax the investments when they are withdrawn from the account in retirement.

Yet our beloved government has managed to complicate this simple concept. Let’s start with the types of retirement accounts. If you think there is just a 401k or IRA, think again. Here’s just a partial list:

• Traditional 401k

• Roth 401k

• Self-Directed 401k

• Safe-Harbor 401k

• Tiered Profit Sharing 401k

• Simple 401k (my personal favorite)

• Individual Retirement Arrangement (IRA)

• Roth IRA

• SEP IRA

• Inherited IRA

stock exchange hours: Progenics Pharmaceuticals Inc.(PGNX)

Advisors’ Opinion:

  • [By Ben Levisohn]

    After meeting with the senior management team of Progenics (PGNX) , Valeant’s partner for oral Relistor, we continue to think that this drug would be a good addition to Valeant’s GI (gastrointestinal) franchise. The PDUFA date for oral Relistor is 7/19/16. AlthoughValeant is leading interactions with the FDA, Progenics is highly confident regarding an approval in July based on its discussions with Valeant. Progenics believes that oral Relistor could be a $1B+ opportunity for Valeant, even with the recent decrease in opioid usage. For context, we estimate ’16 sales of $9.9B for Valeant. An approval for oral Relistor would also help remind the Street that Valeant’s brand drug pipeline is underappreciated, in our view. We think pipeline advancements for brand drugs could drive multiple expansion forValeant shares (on P/E).

  • [By Lisa Levin]

    Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) shares shot up 29 percent to $6.37 after announcing the FDA approval of RELISTOR tablets for the treatment of opioid-induced constipation in adults with chronic non-cancer pain.

stock exchange hours: Cara Therapeutics, Inc.(CARA)

Advisors’ Opinion:

  • [By Javier Hasse]

    On the other hand, Cara Therapeutics Inc (NASDAQ: CARA) was up almost 1.9 percent in what also looked like a correction of the 1.6 percent gain registered over the regular trading session.

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Cara Therapeutics (CARA) , Verizon (VZ) , Radius Health (RDUS) and Six Flags (SIX) .

    Cramer was bearish on Hertz Global Holdings (HTZ) , General Motors (GM) , Pandora Media (P) , Cedar Fair (FUN) , Quotient Technology (QUOT) and Rite Aid (RAD) .

stock exchange hours: Sociedad Quimica y Minera S.A.(SQM)

Advisors’ Opinion:

  • [By Beth McKenna]

    Most investors interested in gaining exposure to the lithium space should stick with investing in one or more of the large players listed on a major U.S. stock exchange:Albemarle Corporation(NYSE:ALB), FMC Corp. (NYSE:FMC), andSociedad Quimica y Minera de Chile(NYSE:SQM), or SQM. Smaller players are speculative to varying degrees, and most are unprofitable.

stock exchange hours: S&P Smallcap 600(PH)

Advisors’ Opinion:

  • [By Charles Mizrahi, President and CEO, Hampton Investors, Inc.]

    Parker Hannifin (PH) generates strong revenue from its aerospace division, while its primary industrial segment is lagging.

    Overall, we like the company’s balanced portfolio. PH had solid order rates this past year with backlog of $3.6 billion between its industrial and aerospace segments.

stock exchange hours: Lumber Liquidators Holdings, Inc(LL)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap hardwood flooring stockLumber Liquidators Holdings Inc (NYSE: LL) reportedQ2 2017 earnings before the market opened this morning with better than expected earnings sending shares soaring as the Company went into earnings with short interest of 24.68% according to Highshortinterest.com. Net sales increased10.7% to $263.5 million as net sales in comparable stores increased 8.8% driven by a 5.3% increase in the number of customers invoiced and a 3.5% increase in the average sale. Merchandise sales in comparable stores grew 6.1% in the quarter whilenet sales in non-comparable stores increased $4.4 million. The Company did not open any stores during the second quarter of 2017 with the total store count remaining at 385 as of June 30, 2017. Net income was $4.5 million versusa net loss of $12.2 million for the first profit in the wake of a 2015 “60 Minutes” report that claimed the Companys laminate flooring contained high levels of cancer-causing formaldehyde.

  • [By Peter Graham]

    The Q4 2016 earnings report for small cap hardwood flooring stockLumber Liquidators Holdings Inc (NYSE: LL) is scheduled for before the market opens onTuesday (February 21th). Lumber Liquidators Holdingshad been ahighflying stock until the middle of 2013 when shares were hit be allegations that the companys flooring products contained illegal levels of formaldehyde. Shares then took another hit on reports that the Department of Homeland Security andthe USFish and Wildlife Servicehad executed a sealed court-issuedsearch/raid on theheadquarters for possible sourcing violations.Lumber Liquidators Holdingslater won a favorable ruling in a California lawsuit filed under the state’s Proposition 65 covering cancer-causing chemicals and agreed to pay $2.5 million (without admitting wrongdoing) to settle a civil matter with the California Air Resources Board.

  • [By Jeremy Bowman]

    Shares ofLumber Liquidators Holdings, Inc.(NYSE:LL) were moving higher last month, though there was little company-specific news out on the stock. The retailer of wood flooring and other related products had been battered in recent years after a scandal involving illegally treated flooring, but investor confidence seemed to be returning along with a general uptick in home-improvement stocks. According to data from S&P Global Market Intelligence, the stock rose 18.4% in March.

stock exchange hours: Sandstorm Gold Ltd(SAND )

Advisors’ Opinion:

  • [By Rich Duprey]

    Sandstorm Gold (NYSEMKT:SAND) has outperformed the precious metal itself over the past year, with shares rising 35% year to date. Last month it reported third-quarter profits of $7 million, a big U-turn from 2015, when it suffered losses of $5.5 million. In fact, its entire operation was doing better with greater production: lower cash costs, but higher cash margins; and greater operating cash flows, all of which allowed it to pay down its revolving credit facility. That means it has no bank debt and its entire $110 million revolving credit facility is available to make acquisitions.

Best High Tech Stocks To Invest In Right Now

Police in India have arrested a man they say was the ringleader of a network of call centers that allegedly swindled thousands of Americans out of millions of dollars.

Sagar Thakkar, 24, was detained in Mumbai after arriving on a flight from Dubai on Saturday.

“He was the mastermind of IRS scam call centers in the state of Maharashtra and one center in Ahmedabad,” said Mukund Hatote, assistant commissioner of police in Thane, just north of Mumbai.

Hatote said Thakkar stands accused of extortion, cheating, impersonation, criminal conspiracy as well as violating India’s communications and tech laws.

News of the scam broke last October when Indian police raided nine calls centers — eight in Thane in Maharashtra — and arrested more than 70 people on suspicion of posing as IRS agents to steal cash from U.S. citizens.

Workers at bogus call centers used American accents to impersonate IRS agents. They told their victims that they owed back taxes and would risk arrest if they hung up or failed to pay up.

Best High Tech Stocks To Invest In Right Now: DAVIDsTEA Inc.(DTEA)

Advisors’ Opinion:

  • [By Monica Gerson]

    DavidsTea Inc (NASDAQ: DTEA) is expected to post its quarterly earnings at $0.43 per share on revenue of $71.74 million.

    SemiLEDs Corporation (NASDAQ: LEDS) is estimated to post its quarterly earnings.

Best High Tech Stocks To Invest In Right Now: Progenics Pharmaceuticals Inc.(PGNX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) shares shot up 29 percent to $6.37 after announcing the FDA approval of RELISTOR tablets for the treatment of opioid-induced constipation in adults with chronic non-cancer pain.

  • [By Ben Levisohn]

    After meeting with the senior management team of Progenics (PGNX) , Valeant’s partner for oral Relistor, we continue to think that this drug would be a good addition to Valeant’s GI (gastrointestinal) franchise. The PDUFA date for oral Relistor is 7/19/16. AlthoughValeant is leading interactions with the FDA, Progenics is highly confident regarding an approval in July based on its discussions with Valeant. Progenics believes that oral Relistor could be a $1B+ opportunity for Valeant, even with the recent decrease in opioid usage. For context, we estimate ’16 sales of $9.9B for Valeant. An approval for oral Relistor would also help remind the Street that Valeant’s brand drug pipeline is underappreciated, in our view. We think pipeline advancements for brand drugs could drive multiple expansion forValeant shares (on P/E).

Best High Tech Stocks To Invest In Right Now: HP Inc.(HPQ)

Advisors’ Opinion:

  • [By Ashraf Eassa]

    Although the personal computer market is down overall, there were some winners and losers among the major personal computer vendors. IDC’s press release included significant details of the performances of the top five personal computer vendors by units — Lenovo (NASDAQOTH:LNVGY), HP Inc (NYSE:HPQ), Dell, ASUS, and Apple (NASDAQ:AAPL).

  • [By Tim Brugger]

    HP (NYSE:HPQ) enjoyed nearly unanimous positive industry reviews surrounding its slew of new or upgraded devices released at the recent Consumer Electronics Show (CES). While the multiple devices wowed at CES, it could be argued that HP’s approach to product sales, as much as the products themselves, is what’s driving its success in the PC market. Taking that a step further, the same tack HP so clearly exhibited at CES should turn its printing fortunes around as well.

  • [By Chris Lange]

    HP Inc. (NYSE: HPQ) is set to reveal its fiscal fourth-quarter results on Tuesday as well. The consensus estimates call for $0.36 in EPS but $11.88 billion in revenue. Shares were trading at $15.87 on Friday. The consensus price target is $16.27. The 52-week range is $8.91 to $16.19.

  • [By Peter Graham]

    The full Q4 2016 earnings report for small cap 3D printing stockStratasys, Ltd (NASDAQ: SSYS)is scheduled for before the market opens onThursday (March 9th). Its hard to see 3D printing stocks regaining their former highs any time soon as HP Inc (NYSE: HPQ) has entered the3D printer market with its Jet Fusion 3D. However,it appears that 3D printing stockshave stabilized as the short interest has largely been cleared out.

Best High Tech Stocks To Invest In Right Now: Haynes International, Inc.(HAYN)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, basic materials shares fell 0.44 percent. Meanwhile, top losers in the sector included Haynes International, Inc. (NASDAQ: HAYN), down 5 percent, and Gibraltar Industries Inc (NASDAQ: ROCK), down 4 percent.

  • [By Lisa Levin]

    Basic materials sector was the top gainer in the US market on Monday. Top gainers in the sector included Haynes International, Inc. (NASDAQ: HAYN), Cliffs Natural Resources Inc (NYSE: CLF), and Olympic Steel, Inc. (NASDAQ: ZEUS).

  • [By Lisa Levin]

    In trading on Wednesday, basic materials shares fell by 1.24 percent. Meanwhile, top losers in the sector included Haynes International, Inc. (NASDAQ: HAYN), down 12 percent, and McEwen Mining Inc (NYSE: MUX), down 9 percent.

Best High Tech Stocks To Invest In Right Now: Myers Industries, Inc.(MYE)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, basic materials shares fell 0.63 percent. Meanwhile, top losers in the sector included Myers Industries, Inc. (NYSE: MYE), down 7 percent, and CF Industries Holdings, Inc. (NYSE: CF) down 6 percent.

Top Performing Stocks To Own For 2018

Small cap restaurant stock Noodles & Co (NASDAQ: NDLS) reportedQ1 2017 earnings after yesterdays market close. In February,Noodles & Co hadannouncedthe completion of an $18.5 million private placement sale of Series A Convertible Preferred Stock and warrants to purchase shares of the Company’s Class A Common Stock to an existing shareholder to strengthen the Company’s balance sheet and fund strategic initiatives. The Company also announced plans to close approximately 55 underperforming company-owned restaurants, to eliminate the negative cash flow of these restaurants and improve overall performance.

Q1 total revenue increased 2.4% to$2.7 million as aresult of new restaurants opened system-wide since the beginning of the first quarter of 2016, partially offset by the closure of 39 company-owned restaurants on February 28, 2017. An additional 16 restaurants were closed at the end of the quarter, and accordingly, their closure did not impact the first quarter revenue results. Additionally, average unit volumes (“AUVs”) for the quarter overall decreased $34,000 compared to the first quarter of 2016. AUV’s for the trailing twelve months were $1,067,000 andexcluding restaurants that were closed during the first quarter, AUV’s were $1,116,000. Noodles & Co reported a net loss of $26.8 million versus a net loss of $2.4 million as the Company recorded $19.9 million of charges related to the closure of 55 restaurants and $1.9 million of charges related to impairment of four restaurants.

Top Performing Stocks To Own For 2018: PetMed Express, Inc.(PETS)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Blue Buffalo Pet Products roughly back up to its IPO close for retail investors while fresh pet food peer Freshpet Inc (NASDAQ: FRPT) isstill below IPO levels and pet stocksCentral Garden & Pet Co (NASDAQ: CENT) andPetmed Express (NASDAQ: PETS) have been much stronger performers in the pet sector after PetSmart (NASDAQ: PETM) was acquired by a private equity group:

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11
  • [By Peter Graham]

    Small cap pet stockPetmed Express Inc (NASDAQ: PETS) reportedQ2 earnings before the market opened this morning with shares soaring this morning as earnings were well beyond expectations. Net sales increased 10% to $66.7 million as new order sales increased 9% to $11.6 million while the Company’s online sales for the quarter ended September 30, 2017 were approximately 84% of all sales compared to 82% for the same quarter the prior year (with online sales increasing 12%). Net income was $8.8 million versusnet income of $4.9 million. The CEO commented:

  • [By Peter Graham]

    A long term performance chart shows Blue Buffalo Pet Products now roughly back up to its IPO close for retail investors while fresh pet food peer Freshpet Inc (NASDAQ: FRPT) is well below IPO levels and pet stocksCentral Garden & Pet Co (NASDAQ: CENT) andPetmed Express (NASDAQ: PETS) have been the best performers in the pet sector after PetSmart (NASDAQ: PETM) was acquired by a private equity group:

  • [By Lisa Levin]

    Monday afternoon, the non-cyclical consumer goods & services shares surged 0.22 percent. Meanwhile, top gainers in the sector included Petmed Express Inc (NASDAQ: PETS), up 20 percent, and Kroger Co (NYSE: KR), up 3 percent.

Top Performing Stocks To Own For 2018: Electronics for Imaging Inc.(EFII)

Advisors’ Opinion:

  • [By Lisa Levin]

    Electronics For Imaging, Inc. (NASDAQ: EFII) shares dropped 43 percent to $26.96. Electronics For Imaging disclosed that it has postponed Q2 release due to accounting issues related to revenue recognition. Morgan Stanley downgraded Electronics for Imaging from Equal-Weight to Underweight.

Top Performing Stocks To Own For 2018: International Game Technology(IGT)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Thursday was another strong day on Wall Street, with major benchmarks posting gains across the board. The S&P 500 reached another all-time high on strength from an upbeat view of the economy and good earnings results from major companies in the retail sector. Although energy prices sagged, investors seemed to focus on the cost savings that consumers would enjoy from cheaper gasoline rather than the profit hit that major oil and natural gas companies might suffer. Still, not every stock participated in the rally, and International Game Technology (NYSE:IGT), Genesco (NYSE:GCO), and Ensco (NYSE:ESV) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Dan Caplinger]

    Yet even though the overall market remained resilient in the face of some threats to positive sentiment among investors, some stocks posted substantial losses. Stratasys (NASDAQ:SSYS), International Game Technology (NYSE:IGT), and Momo (NASDAQ:MOMO) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Michael Flannelly]

    Analysts at Sterne Agee noted on Monday that International Game Technology’s (IGT) fiscal 2014 growth is stronger than it appears. As such, the analysts raised the price target on the casino gaming equipment manufacturer.

    The analysts maintain a “Buy” rating on IGT and now see shares reaching $25, up from the previous target of $23. This new price target suggests a 23% upside to the stock’s Friday closing price of $20.32.

    “Excluding FY13 Canadian VLT sales, which do not recur in FY14, consensus FY14 EPS growth is ~14% versus ‘in-print’ consensus EPS growth of ~4%,” Sterne Agee analyst David Bain said. “We believe IGT’s peer-low stock valuation is partly driven by a misinterpretation of forward growth using ‘in-print’ FY14 EPS projections.”

    Futhermore, the firm raised IGT’s fourth quarter EPS estimates from 33 cents to 34 cents.

    IGT shares were inactive during pre-market trading on Monday. The stock is up 43.4% year-to-date.

Top Performing Stocks To Own For 2018: Progenics Pharmaceuticals Inc.(PGNX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) shares shot up 29 percent to $6.37 after announcing the FDA approval of RELISTOR tablets for the treatment of opioid-induced constipation in adults with chronic non-cancer pain.

  • [By Ben Levisohn]

    After meeting with the senior management team of Progenics (PGNX) , Valeant’s partner for oral Relistor, we continue to think that this drug would be a good addition to Valeant’s GI (gastrointestinal) franchise. The PDUFA date for oral Relistor is 7/19/16. AlthoughValeant is leading interactions with the FDA, Progenics is highly confident regarding an approval in July based on its discussions with Valeant. Progenics believes that oral Relistor could be a $1B+ opportunity for Valeant, even with the recent decrease in opioid usage. For context, we estimate ’16 sales of $9.9B for Valeant. An approval for oral Relistor would also help remind the Street that Valeant’s brand drug pipeline is underappreciated, in our view. We think pipeline advancements for brand drugs could drive multiple expansion forValeant shares (on P/E).